Peter Schmid-Grendelmeier

Head Allergy Unit

Spital Davos AG

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Schmid-Grendelmeier is the Head of the Allergy Unit at Hochgebirgsklinik Davos, Switzerland. His research focuses on atopic dermatitis, hypersensitivity reactions, and allergy management, as evidenced by his recent publications. He investigates the intersection of environmental factors and allergic responses, as well as novel treatment modalities for allergic conditions.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (6)

Jakob Nilsson

SWITZERLAND

View details

Bernard Alain Clot

Head Biometeorology

SWITZERLAND

View details

Julia-Tatjana Maul

University Hospital of Zurich

SWITZERLAND

View details

Erika Jensen‐Jarolim

AUSTRIA

View details

George Konstantinou

Head

GREECE

View details

Antonia Fettelschoss‐Gabriel

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Schmid-Grendelmeier

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Examining Atopic Dermatitis Through the One Health Concept Lens

Perioperative Hypersensitivity Reactions: An Analysis of Affected Patients, Responsible Agents, and Conducted Diagnostics at a Tertiary Allergology University Center in Switzerland

Possible In‐Cabin Exposure to Cat Allergen: A 2025 Airline Survey on Live Animal Transport and a Review of Literature

Uncovering the Distinct Role of Phleum p 4 in Grass Pollen Allergy: Sensitization Patterns in 1963 Swiss Patients

Relationship between antihistamine residues in wastewater and airborne pollen concentrations: Insights into population-scale pollinosis response

Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis and comorbid allergies

Fast Itch Relief during Dupilumab Predicts Clinical Efficacy in Bullous Pemphigoid: A Retrospective Cohort Study

Nodular Vasculitis: Retrospective Study of an Uncommon Disease in a Non-Tuberculosis Endemic Country with Focus on Treatment Modalities and Efficacy

Disease burden of moderate–severe atopic dermatitis by use of systemic treatment: Results from the Danish Skin Cohort

How to integrate atopic dermatitis in the management of skin neglected tropical diseases in Sub‐Saharan Africa?

Collaborators (6)

Jakob Nilsson

Bernard Alain Clot

Julia-Tatjana Maul

Erika Jensen‐Jarolim

George Konstantinou

Antonia Fettelschoss‐Gabriel

Make your next move.